Aeon Biopharma Inc (AEON)

$2.63

-0.3

(-10.24%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $2.52
    $2.96
    $2.63
    downward going graph

    4.18%

    Downside

    Day's Volatility :14.86%

    Upside

    11.15%

    downward going graph
  • $0.92
    $17.17
    $2.63
    downward going graph

    65.11%

    Downside

    52 Weeks Volatility :94.66%

    Upside

    84.68%

    downward going graph

Returns

PeriodAeon Biopharma IncIndex (Russel 2000)
3 Months
-42.21%
0.0%
6 Months
-66.28%
0.0%
1 Year
-52.59%
0.0%
3 Years
-69.7%
-20.2%

Highlights

Market Capitalization
103.3M
Book Value
- $5.2
Earnings Per Share (EPS)
-0.54
Wall Street Target Price
6.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-374.77%
Return On Equity TTM
0.0%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-50.1M
Diluted Eps TTM
-0.54
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-3.8
EPS Estimate Next Year
-0.87
EPS Estimate Current Quarter
-0.31
EPS Estimate Next Quarter
-0.31

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Aeon Biopharma Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 128.14%

Current $2.63
Target $6.00

Technicals Summary

Sell

Neutral

Buy

Aeon Biopharma Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aeon Biopharma Inc
Aeon Biopharma Inc
190.1%
-66.28%
-52.59%
-69.7%
-69.64%
Moderna, Inc.
Moderna, Inc.
-1.67%
18.26%
-0.21%
-64.15%
752.69%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.46%
13.21%
45.59%
84.19%
244.2%
Novo Nordisk A/s
Novo Nordisk A/s
-11.0%
18.31%
61.56%
186.46%
423.59%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.85%
14.43%
39.88%
147.45%
195.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aeon Biopharma Inc
Aeon Biopharma Inc
NA
NA
NA
-3.8
0.0
-3.75
NA
-5.2
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.35
31.35
1.46
44.44
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
44.28
44.28
2.36
3.43
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
16.98
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aeon Biopharma Inc
Aeon Biopharma Inc
Buy
$103.3M
-69.64%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$45.3B
752.69%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$116.9B
244.2%
31.35
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$572.0B
423.59%
44.28
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
195.07%
31.85
39.46%

Insights on Aeon Biopharma Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 114.2%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 256.2%

Company Information

we are a nasdaq-listed special purpose acquisition company whose business purpose is to effect a merger or similar business combination with one or more businesses. our acquisition strategy is to identify and complete our initial business combination with a medical technology company in the healthcare industry. our sponsor team consists of chairman/ceo robert palmisano, president vikram malik, cfo oleg grodnensky and chief legal officer david meredith.

Organization
Aeon Biopharma Inc
Employees
10
CEO
Mr. Marc Forth
Industry
Miscellaneous

Discover More

FAQs